Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(800)
•••
Post by SouthernTierTomon Dec 22, 2020 11:38pm
133 Views
Post# 32167130

Who is driving this "Chuck Wagon"?

Who is driving this "Chuck Wagon"?How do we gain a value of "1 cent per world renowned center's patient"?

Really...no wonder the kids want to talk phony politics...

So roughly 18 patients now?  a couple less for effect, let's call it 1 penny USD / patient...

Didn't Greenwich just go to $158 USD per share on good phase 2 news?

Hmmmmmmm...tax loss, Trump, animal data - LOL

Whilst they laser peeps bladders at Princess Maggie, we have the urologist's brotha talk up small animal data as it relates to covid?

Do "they" assume everyone is drunk, high or both?

Too bad the stock hit 17, it must be hard at this time of the year to run a bullboard program on a company lasering cancerous bladders at NA's #3 rated cancer centre

Wish I had bought Kev's LSD play LOL

God Bless the Beech Boys, they'll need it when they arrive at the "gates"...wear layered clothing, it could be a little warmer where youre redirected
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities